4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-22-026891
EVP and COO sold 330 shares at $11.75 ($3,878)
- EVP and COO acquired 962 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wolff Stefani EVP and COO | 2022-04-30 | Option exercise | +962 | 962 | D: show line 1 in the form | ||
| Wolff Stefani EVP and COO | 2022-05-02 | Sale | −330 | $11.75 | $3,878 | 632 | D: show line 2 in the form |
| Open-market sales · 330 sh · avg $11.75 · $3,878 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Wolff Stefani EVP and COO | 2022-04-30 | Option exercise · Restricted Stock Units | −962 | 14,430 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…